Researchers combine MERS and rabies viruses to create innovative 2-for-1 vaccine

December 7, 2016
MERS is a viral infectious disease caused by a coronavirus and results in pneumonia and respiratory distress syndrome. The disease has been localized in Middle Eastern countries, most notably, Saudi Arabia, Qatar and United Arab Emirates, mainly transmitted from dromedary camels to humans. Human-to-human transmission is rare, but can occur in close contact. Coronaviruses have a protective protein capsule and what appears to be a "crown" of projections from the surface of the virus, visible in this image. Credit: Public domain

In a new study, researchers have modified a rabies virus, so that it has a protein from the MERS virus; this altered virus works as a 2-for-1 vaccine that protects mice against both Middle East Respiratory Syndrome (MERS) and rabies.

Because it uses an already-tested for rabies, the innovative combination could speed development of a MERS vaccine for humans. Currently no vaccine exists for this new and highly fatal . The study, published in the latest issue of the Journal of Virology, found that the vaccine protected mice from infection with MERS.

"This is the first time anyone has used this strategy to create a MERS vaccine," said the lead researcher on the study, Matthew B. Frieman, an associate professor of microbiology and immunology at the school. "This could give us a powerful mechanism to fight the virus."

MERS has killed more than 630 people since it was first discovered four years ago in Saudi Arabia. It has infected more than 1,800, meaning that about a third of those who are infected die - a very high fatality rate for an infectious disease. It appears that the disease spreads to humans from camels, who may themselves been infected by bats. Research has shown that MERS is similar to Severe acute respiratory syndrome (SARS), which emerged in 2003 and resulted in more than 8,000 infections, killing 10 percent of patients. Both diseases, which are caused by Coronaviruses, cause serious respiratory problems.

Through genetic engineering, Dr. Frieman and his colleagues produced a modified that expresses a protein from the surface of the MERS virus, known as a spike protein, on the surface of the rabies virus. He describes the MERS protein as a looking like a "lollypop sticking out a tennis ball." Through an existing, FDA-approved process, scientists then treated the modified virus chemically, inactivating it so that it cannot replicate. This inactivated virus is itself the vaccine, which triggers an immune response but poses no danger to the recipient.

Because it included the MERS spike protein, the dual compound also triggered an immune response to MERS. In tests on mice, the MERS-rabies vaccine protected against both diseases. The double vaccine could prove useful not only in humans, but in camels, which are the reservoir of the disease. About 95 percent of camels in the Middle East are infected with MERS when they are young; because their immune system reacts differently from humans', it gives them the sniffles rather than kills them. But if they were vaccinated against MERS - many of them already receive the - they would not be able to spread the disease to humans. Dr. Frieman is now planning to begin testing the approach in camels.

In another recent paper, also published in the latest issue of the Journal of Virology, Dr. Frieman examined how the body responds to MERS. He examined a range of immune cells, to see which play the largest role in the body's response to the virus. He examined three types of immune cell in particular: CD8 T cells, CD4 T cells, and macrophages. It appears that macrophages play a much larger role than the other two in protecting the body, at least in a mouse model of disease. With this knowledge, researchers will now try to understand how macrophages accomplish this. By unraveling this, they could come up with better strategies to fight MERS.

Explore further: Vaccine proves effective against deadly Middle East virus

Related Stories

Vaccine proves effective against deadly Middle East virus

September 15, 2014
(Medical Xpress)—A vaccine developed by an international team of scientists led by the University of Pittsburgh School of Medicine successfully protects mice against a contagious and deadly virus spreading across the Middle ...

Oman reports first MERS death in nearly a year

January 8, 2015
Oman reported Thursday its first death of a person from Middle East Respiratory Syndrome coronavirus (MERS-CoV) in nearly a year.

Scientists find mystery virus in camels in Qatar

November 29, 2013
Health officials say they have found a mysterious respiratory virus in a herd of camels in Qatar linked to two human cases of the disease.

Saudi man dies of MERS virus: ministry

July 28, 2013
A Saudi man has died of the coronavirus MERS and another has contracted the virus, the health ministry said on Saturday, bringing the kingdom's deaths from the virus to 39.

Saudi records 60th MERS virus death

February 16, 2014
Saudi health authorities have announced the death of a young man from the MERS coronavirus, bringing the death toll from the respiratory disease in the kingdom to 60.

MERS virus kills man in UAE

January 27, 2016
The MERS coronavirus has killed a man in the United Arab Emirates, the Abu Dhabi health authority said on Tuesday.

Recommended for you

Two Group A Streptococcus genes linked to 'flesh-eating' bacterial infections

September 22, 2017
Group A Streptococcus bacteria cause a variety of illnesses that range from mild nuisances like strep throat to life-threatening conditions including pneumonia, toxic shock syndrome and the flesh-eating disease formally known ...

Ecosystem approach makes urinary tract infection more treatable

September 22, 2017
The biological term 'ecosystem' is not usually associated with urinary tract infections, but this should change according to Wageningen scientists.

Residents: Frontline defenders against antibiotic resistance?

September 22, 2017
Antibiotic resistance continues to grow around the world, with sometimes disastrous results. Some strains of bacteria no longer respond to any currently available antibiotic, making death by infections that were once easily ...

Superbug's spread to Vietnam threatens malaria control

September 21, 2017
A highly drug resistant malaria 'superbug' from western Cambodia is now present in southern Vietnam, leading to alarming failure rates for dihydroartemisinin (DHA)-piperaquine—Vietnam's national first-line malaria treatment, ...

Investigators may unlock mystery of how staph cells dodge the body's immune system

September 21, 2017
For years, medical investigators have tried and failed to develop vaccines for a type of staph bacteria associated with the deadly superbug MRSA. But a new study by Cedars-Sinai investigators shows how staph cells evade the ...

Individualized diets for irritable bowel syndrome better than placebo

September 21, 2017
Patients with irritable bowel syndrome who follow individualized diets based on food sensitivity testing experience fewer symptoms, say Yale researchers. Their study is among the first to provide scientific evidence for this ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.